Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Varlilumab (Anti-TNFRSF7 / CD27) For research use only.
Not for use in humans.

Varlilumab (Anti-TNFRSF7 / CD27)

Synonyms: CDX-1127

Varlilumab (Anti-TNFRSF7 / CD27) is a human monoclonal antibody with activity against the CD27 receptor. It exhibits potential immunostimulating and antineoplastic activity. MW : 150 KD.

Varlilumab (Anti-TNFRSF7 / CD27)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Varlilumab (Anti-TNFRSF7 / CD27) is a human monoclonal antibody with activity against the CD27 receptor. It exhibits potential immunostimulating and antineoplastic activity. MW : 150 KD.

Product Details

CAS No. 1393344-72-3
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Varlilumab (Anti-TNFRSF7 / CD27) | Varlilumab (Anti-TNFRSF7 / CD27) supplier | purchase Varlilumab (Anti-TNFRSF7 / CD27) | Varlilumab (Anti-TNFRSF7 / CD27) cost | Varlilumab (Anti-TNFRSF7 / CD27) manufacturer | order Varlilumab (Anti-TNFRSF7 / CD27) | Varlilumab (Anti-TNFRSF7 / CD27) distributor